Paper published!

Congratulations Jeremy, who has kicked off the year with the publication of his paper “Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma” in the European Journal of Cancer. This multi-centre international retrospective cohort study confirms the real-world efficacy of anti-PD-(L)1 therapy for advanced MCC, and provides valuable insight into the utility of platinum doublet chemotherapy or anti-PD-(L)1 rechallenge in the face of tumour progression. This work was carried out with Ines Pires da Silva and colleagues at Westmead Hospital. Congratulations Jeremy!